Background & Aims Large prospective studies to establish the prevalence of non-alcoholic
fatty liver disease (NAFLD) and steatohepatitis (NASH), are lacking. We prospectively …

In nonalcoholic fatty liver disease, hepatic gene expression and fatty acid (FA) composition
have been reported independently, but a comprehensive gene expression profiling in …

Background & Aims Little is known about the prevalence of nonalcoholic fatty liver disease
(NAFLD) among severely obese adolescents or factors that determine its development. We …

Increased consumption of high-caloric carbohydrates contributes substantially to endemic
non-alcoholic fatty liver disease in humans, covering a histological spectrum from fatty liver …

Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide and the
third most common cancer in Asia. HCC has heterogeneous etiologic and molecular profiles …

Introduction: It is generally accepted that metabolic inflammation in the liver is an important
driver of disease progression in NASH and associated matrix remodeling/fibrosis. However …

Nonalcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (AFLD) are so
similar that only a detailed history of alcohol intake can distinguish one from the other …

Aims Pentoxifylline has been used to treat nonalcoholic fatty liver diseases (NAFLDs) due to
its anti-tumor necrosis factor-α effects. We conducted a meta-analysis of randomized, double …

Objective The aim of this study was to determine whether hepatic gene expression related to
hepatocellular carcinoma (HCC) is associated with disease severity and modifiable lifestyle …

Aim Non‐alcoholic fatty liver disease (NAFLD) progresses because of the interaction
between numerous genes. Thus, we carried out a weighted gene coexpression network …